Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pozet

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Urological Research|January 1, 1981
Cystine crystalluria and urinary saturation in cystine and non-cystine stone formersM Labeeuw, C Gerbaulet, N Pozet, et al.
European Journal of Clinical Pharmacology|November 14, 1977
Pharmacokinetics of atenolol in patients with renal impairmentJ Sassard, N Pozet, J McAinsh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Creatinine determination in peritoneal dialysis: what method should be used?N Ferry, A Caillette, J Goudable, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1988
Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertensionO Madonna, M Labeeuw, N Pozet, et al.
Nephron|January 1, 1985
Separate calculation of glomerular and tubular clearance by means of renal scintigraphy with hippuran and DTPAA Hadj Aissa, M Collard, N Pozet, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Spontaneous variations in the renal handling of uric acidN Pozet, M Labeeuw, A Hadj Aissa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1987
Evolution of renal function under chronic oral administration of labetalolM Labeeuw, P Zech, N Pozet, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Magnesuria induced by thiazides and the influence of triamtereneM Labeeuw, N Pozet, P Zech, et al.
Journal De Pharmacologie|January 1, 1983
[Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient]J Sassard, P Y Zech, N Pozet, et al.
British Journal of Clinical Pharmacology|January 1, 1981
Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiencyA Hadj Aissa, N Pozet, M Labeeuw, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Urological Research|January 1, 1981
Cystine crystalluria and urinary saturation in cystine and non-cystine stone formersM Labeeuw, C Gerbaulet, N Pozet, et al.
European Journal of Clinical Pharmacology|November 14, 1977
Pharmacokinetics of atenolol in patients with renal impairmentJ Sassard, N Pozet, J McAinsh, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Creatinine determination in peritoneal dialysis: what method should be used?N Ferry, A Caillette, J Goudable, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1988
Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertensionO Madonna, M Labeeuw, N Pozet, et al.
Nephron|January 1, 1985
Separate calculation of glomerular and tubular clearance by means of renal scintigraphy with hippuran and DTPAA Hadj Aissa, M Collard, N Pozet, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Spontaneous variations in the renal handling of uric acidN Pozet, M Labeeuw, A Hadj Aissa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1987
Evolution of renal function under chronic oral administration of labetalolM Labeeuw, P Zech, N Pozet, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Magnesuria induced by thiazides and the influence of triamtereneM Labeeuw, N Pozet, P Zech, et al.
Journal De Pharmacologie|January 1, 1983
[Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient]J Sassard, P Y Zech, N Pozet, et al.
British Journal of Clinical Pharmacology|January 1, 1981
Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiencyA Hadj Aissa, N Pozet, M Labeeuw, et al.
Pageof 14